Picture of Basilea Pharmaceutica AG, Allschwil logo

BSLN — Basilea Pharmaceutica AG, Allschwil News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Basilea Receives USD 39 Mln Funding

July 8 (Reuters) - BASILEA PHARMACEUTICA AG ALLSCHWIL BSLN.S:

RECEIVES USD 39 MILLION FUNDING UNDER BARDA AGREEMENT TO CONTINUE TO ADVANCE NOVEL ANTIFUNGALS FOSMANOGEPIX AND BAL2062

Source text: ID:nGNX69STGF

Further company coverage: BSLN.S

 (Gdansk Newsroom)

 ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Basilea Pharmaceutica AG, Allschwil

See all news